Hospital-Acquired Pneumonia Prevention Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global hospital-acquired pneumonia prevention market is set to experience substantial growth over the next few years, driven by an aging population and a noticeable decline in immunity levels among the elderly. These dual factors underscore the pressing need for effective pneumonia prevention strategies in healthcare settings worldwide. A recent report by Fairfield Market Research projects robust market expansion during the forecast period of 2024-2031, highlighting several key drivers and trends shaping this growth.

Aging Population and Immunity Decline: Catalysts for Market Expansion

The increasing prevalence of chronic diseases, longer hospital stays, and emerging industry trends such as medical tourism are pivotal in driving the demand for hospital-acquired pneumonia prevention. With a growing elderly population, there is a heightened risk of pneumonia due to weakened immune systems, making prevention measures more critical than ever.

Oral Care Kits: A Cornerstone of Prevention

One of the standout findings from the report is the pivotal role that oral care products and kits are poised to play in preventing hospital-acquired pneumonia. As more countries mandate standardized pneumonia prevention protocols, including rigorous oral care in Intensive Care Units (ICUs) and Critical Care Units (CCUs), the demand for oral care kits is expected to witness significant growth. These protocols are essential in reducing the incidence of pneumonia, particularly among patients in vulnerable conditions.

Emerging Economies: Opportunities Abound

The report also highlights burgeoning opportunities in emerging economies, especially in Southeast Asia, where the incidence of pneumonia among hospitalized patients is anticipated to escalate in the near future. The expansion of the patient pool, coupled with increasing adoption of prevention protocols, is expected to drive substantial market growth in these regions. Emerging economies are investing in healthcare infrastructure and adopting advanced medical practices, creating lucrative opportunities for market players.

Product Segmentation Insights

In terms of product segmentation, oral care kits emerge as the frontrunner, accounting for a substantial share of market revenues. This segment is expected to maintain its dominance throughout the forecast period, driven by the increasing emphasis on oral hygiene as a preventive measure against pneumonia. Suction tools follow closely, while other segments, including swabs, toothbrushes, and mouthwashes, also contribute significantly to market growth. These products are integral components of comprehensive pneumonia prevention protocols in healthcare settings.

Standardized Oral Care Protocols: A Game-Changer

The report delves into the importance of standardized oral care protocols for hospital-acquired pneumonia patients, underscoring their role in reducing the incidence of non-ventilator-associated hospital-acquired pneumonia. Enhanced oral care is particularly crucial for care-dependent neurologically impaired patients, who are at higher risk of developing pneumonia. By implementing rigorous oral care routines, healthcare providers can significantly reduce pneumonia cases and improve patient outcomes.

Key Market Drivers and Trends

Several key drivers and trends are shaping the hospital-acquired pneumonia prevention market:

1. Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders increases the risk of pneumonia, necessitating effective prevention strategies.

2. Longer Hospital Stays: Extended hospital stays, especially in ICUs and CCUs, elevate the risk of hospital-acquired infections, including pneumonia, driving the demand for preventive measures.

3. Medical Tourism: The growing trend of medical tourism, particularly in emerging economies, is boosting the demand for advanced healthcare services and pneumonia prevention protocols.

4. Technological Advancements: Innovations in oral care products and suction tools are enhancing the effectiveness of pneumonia prevention measures, contributing to market growth.

Key Market Players Include

Sage Products LLC (Stryker Corporation)
Intersurgical Ltd.
Medline Industries, Inc.
Halyard Health, Inc.
Others.

Global Male Hypogonadism market is Segmented as Below:

By Product Type

Oral Care Kit
Toothbrush
Swab
Moisturizer
Mouth Wash
Suction Tools

By End-user

Hospitals
Rehabilitation Centers

By Region

North America
Latin America
Europe
Asia Pacific excluding China (APEC)
China
Middle East & Africa (MEA)
Home Care Settings

1. Executive Summary

1.1. Global Hospital-Acquired Pneumonia Prevention Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Economic Overview
- 2.6.1. World Economic Projections
2.7. PESTLE Analysis

3. Global Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031

3.1. Global Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Oral Care Kit
  - 3.1.1.2. Toothbrush
  - 3.1.1.3. Swab
  - 3.1.1.4. Moisturizer
  - 3.1.1.5. Mouth Wash
  - 3.1.1.6. Suction Tools
3.2. Global Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospitals
  - 3.2.1.2. Rehabilitation Centers
  - 3.2.1.3. Home Care Settings
3.3. Global Hospital-Acquired Pneumonia Prevention Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031

4.1. North America Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Oral Care Kit
  - 4.1.1.2. Toothbrush
  - 4.1.1.3. Swab
  - 4.1.1.4. Moisturizer
  - 4.1.1.5. Mouth Wash
  - 4.1.1.6. Suction Tools
4.2. North America Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospitals
  - 4.2.1.2. Rehabilitation Centers
  - 4.2.1.3. Home Care Settings
4.3. North America Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031

5.1. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Oral Care Kit
  - 5.1.1.2. Toothbrush
  - 5.1.1.3. Swab
  - 5.1.1.4. Moisturizer
  - 5.1.1.5. Mouth Wash
  - 5.1.1.6. Suction Tools
5.2. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospitals
  - 5.2.1.2. Rehabilitation Centers
  - 5.2.1.3. Home Care Settings
5.3. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031

6.1. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Oral Care Kit
  - 6.1.1.2. Toothbrush
  - 6.1.1.3. Swab
  - 6.1.1.4. Moisturizer
  - 6.1.1.5. Mouth Wash
  - 6.1.1.6. Suction Tools
6.2. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospitals
  - 6.2.1.2. Rehabilitation Centers
  - 6.2.1.3. Home Care Settings
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031

7.1. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Oral Care Kit
  - 7.1.1.2. Toothbrush
  - 7.1.1.3. Swab
  - 7.1.1.4. Moisturizer
  - 7.1.1.5. Mouth Wash
  - 7.1.1.6. Suction Tools
7.2. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031

8.1. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Oral Care Kit
  - 8.1.1.2. Toothbrush
  - 8.1.1.3. Swab
  - 8.1.1.4. Moisturizer
  - 8.1.1.5. Mouth Wash
  - 8.1.1.6. Suction Tools
8.2. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospitals
  - 8.2.1.2. Rehabilitation Centers
  - 8.2.1.3. Home Care Settings
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Sage Products LLC (Stryker Corporation)
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Therapy Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Intersurgical Ltd.
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Therapy Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Medline Industries, Inc.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Therapy Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Halyard Health, Inc.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Therapy Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Others
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Therapy Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development

10. Appendix

10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations